Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
نویسندگان
چکیده
منابع مشابه
Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
BACKGROUND Several papers have shown that quantitationof tumor angiogenesis in primary breast cancer by counting blood vessels gives an independent assessment of prognosis. The impact of chemotherapy +/- endocrine therapy on the extent of angiogenesis is unknown. METHODS Matched pair histological tumor samples were obtained before and after primary chemotherapy from 120 breast cancer patients...
متن کاملKi-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
PURPOSE The objectives of this study were to assess the potential value of Ki-67 in predicting response to neoadjuvant chemotherapy in breast cancer patients and to suggest a reasonable cutoff value for classifying Ki-67 expression. METHODS This study included 74 breast cancer patients who underwent surgery after anthracycline-based neoadjuvant chemotherapy between 2007 and 2012. We analyzed ...
متن کاملAssociation of tumor infiltration lymphocytes and complete pathological response in breast cancer patients under neoadjuvant chemotherapy
Background: The breast cancer is the most common type of cancer in Iran. Hence determination of the optimal treatment and the contributing factors are important. The main aim in current study was to determine the association between tumor infiltration of lymphocytes (TIL) and complete pathological response in breast cancer patients after neoadjuvant chemotherapy. Methods and materials: In this...
متن کاملQuantitative Ultrasound Evaluation of Tumour Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy
(1) Imaging Research Physical Science, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada (2) Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada (3) Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada (4) Department of Radiation Oncology, Faculty of Medici...
متن کاملPRECLINICAL STUDY The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
The 70-gene signature (MammaPrint) is a prognostic tool used to guide adjuvant treatment decisions. The aim of this study was to assess its value to predict chemosensitivity in the neoadjuvant setting. We obtained the 70-gene profile of stage II–III patients prior to neoadjuvant chemotherapy and classified the prognosissignatures. Pathological complete remission (pCR) was used to measure chemos...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 2002
ISSN: 0007-0920,1532-1827
DOI: 10.1038/sj.bjc.6600325